US food benefits for the poor to be reduced as pandemic provisions end

Housing Instability Tied to Lower Rates of CRC Screening

Unmet health-related social needs, especially housing instability and transportation barriers, are linked to lower rates of screening for colorectal cancer among US adults.

Blood Proteins Link Poor Sleep to Increased Cancer Risk

Suboptimal sleep health, reflected in low sleep proteomic scores, is consistently associated with an increased risk for cancer, particularly gastrointestinal malignancies.

Olanzapine Cuts Radiation-Induced Nausea

The drug, widely used for chemotherapy-related nausea, may also be highly effective for symptoms caused by abdominal-pelvic radiotherapy.

Silent Reflux: Clinical Conundrum Solved via Proper Testing

A chronic cough without heartburn are the tell-tale signs of the condition; surgery is typically not the answer.

Barrett Esophagus Onset Occurs Decades Before Diagnosis

Molecular clock modeling suggests that the biological onset of Barrett esophagus occurs more than 20 years before the recommended screening age.

Zenocutuzumab OK’d for NRG1 Fusion+ Cholangiocarcinoma

The bispecific antibody has previously granted accelerated approval for advanced, unresectable, or metastatic non-small cell lung cancer and pancreatic adenocarcinoma harboring the gene fusions.

Sigmoidoscopy Cuts Colorectal Cancer Risk in Men

Researchers randomly assign more than 100,000 adults without CRC to receive once-only sigmoidoscopy screening or no screening between 1999 and 2001. Here’s what they find.

False Positive mt-sDNA Tests Could Flag Other Cancers

False-positive multi-target stool tests are linked to higher rates of noncolorectal aerodigestive cancers, suggesting further workup may be indicated in these patients.

Meeting the Challenge of Accurate and Timely Diagnosis of GEP-NETs

Meeting the Challenge of Accurate and Timely Diagnosis of GEP-NETs

HER2 Testing in Practice: Case-Based Insights to Improve Interpretation, Reporting, and Multidisciplinary Team Collaboration

HER2 Testing in Practice: Case-Based Insights to Improve Interpretation, Reporting, and Multidisciplinary Team Collaboration

Precision Pathways: Matching Test Results to Therapy in Advanced G/GEJ Adenocarcinoma

Precision Pathways: Matching Test Results to Therapy in Advanced G/GEJ Adenocarcinoma

Navigating Personalized Management of Advanced Upper GI Adenocarcinomas

Navigating Personalized Management of Advanced Upper GI Adenocarcinomas

Unlocking MMR and MSI: Paving the Path to Personalized Treatment in Early-Stage CRC

Unlocking MMR and MSI: Paving the Path to Personalized Treatment in Early-Stage CRC

Checkpoint, Claudin, and Beyond: Optimizing Biomarker-Driven Decisions in Advanced/Metastatic G/GEJ Cancer Care

Checkpoint, Claudin, and Beyond: Optimizing Biomarker-Driven Decisions in Advanced/Metastatic G/GEJ Cancer Care

Navigating the Future of Upper GI Cancer Treatment: Mechanisms, Personalization, and Expert Insights

Navigating the Future of Upper GI Cancer Treatment: Mechanisms, Personalization, and Expert Insights

EASL: European Association for the Study of the Liver